ID

32474

Descripción

Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01216527

Link

https://clinicaltrials.gov/show/NCT01216527

Palabras clave

  1. 2/11/18 2/11/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

2 de noviembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Squamous Cell Esophageal Carcinoma NCT01216527

Eligibility Squamous Cell Esophageal Carcinoma NCT01216527

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histologic diagnosis of squamous cell thoracic esophageal carcinoma of stage iib or iii, which is potentially resectable.
Descripción

Squamous cell carcinoma of esophagus Thoracic Resectable TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279626
UMLS CUI [1,2]
C0817096
UMLS CUI [1,3]
C1514888
UMLS CUI [1,4]
C3258246
2. patients must not have received any prior anticancer therapy.
Descripción

Cancer treatment Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0332197
3. more than 6 months of expected survival.
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
4. age ranges from 18 to 70 years.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
5. absolute white blood cells count ≥4.0×109/l, neutrophil ≥1.5×109/l, platelets
Descripción

White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0200633
UMLS CUI [3]
C0032181
≥100.0×109/l, hemoglobin ≥90g/l, and normal functions of liver and kidney.
Descripción

Hemoglobin measurement | Liver function | Renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0518015
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
6. karnofsky performance status (kps) of 90 or more.
Descripción

Karnofsky Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
7. signed informed consent document on file.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients are diagnosed or suspected to be allergic to cisplatin or vinorelbine.
Descripción

Cisplatin allergy | Cisplatin allergy Suspected | Hypersensitivity Vinorelbine | Hypersensitivity Suspected Vinorelbine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0570702
UMLS CUI [2,1]
C0570702
UMLS CUI [2,2]
C0750491
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0078257
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0750491
UMLS CUI [4,3]
C0078257
2. patients with concomitant hemorrhagic disease.
Descripción

Hemorrhagic Disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019087
3. pregnant or breast feeding.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
4. inability to use gastric conduit after esophagectomy because of a prior surgery.
Descripción

Use of Conduit gastric Unable | Status post Esophagectomy | Etiology Operative Surgical Procedures Previous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1524063
UMLS CUI [1,2]
C0441247
UMLS CUI [1,3]
C0038351
UMLS CUI [1,4]
C1299582
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0085198
UMLS CUI [3,1]
C0015127
UMLS CUI [3,2]
C0543467
UMLS CUI [3,3]
C0205156
5. patients with concomitant peripheral neuropathy, whose ctc status is 2 or even more.
Descripción

Peripheral Neuropathy CTCAE Grades

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
6. have a prior malignancy other than esophageal carcinoma, carcinoma in situ of the cervix, nonmelanoma skin cancer or cured early stage of prostate cancer.
Descripción

Malignant Neoplasms | Exception Esophageal carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Skin carcinoma | Exception Prostate carcinoma Early stage Cured

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0152018
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0699893
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0600139
UMLS CUI [5,3]
C2363430
UMLS CUI [5,4]
C0679252

Similar models

Eligibility Squamous Cell Esophageal Carcinoma NCT01216527

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Squamous cell carcinoma of esophagus Thoracic Resectable TNM clinical staging
Item
1. histologic diagnosis of squamous cell thoracic esophageal carcinoma of stage iib or iii, which is potentially resectable.
boolean
C0279626 (UMLS CUI [1,1])
C0817096 (UMLS CUI [1,2])
C1514888 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
Cancer treatment Absent
Item
2. patients must not have received any prior anticancer therapy.
boolean
C0920425 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Life Expectancy
Item
3. more than 6 months of expected survival.
boolean
C0023671 (UMLS CUI [1])
Age
Item
4. age ranges from 18 to 70 years.
boolean
C0001779 (UMLS CUI [1])
White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement
Item
5. absolute white blood cells count ≥4.0×109/l, neutrophil ≥1.5×109/l, platelets
boolean
C0023508 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Hemoglobin measurement | Liver function | Renal function
Item
≥100.0×109/l, hemoglobin ≥90g/l, and normal functions of liver and kidney.
boolean
C0518015 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Karnofsky Performance Status
Item
6. karnofsky performance status (kps) of 90 or more.
boolean
C0206065 (UMLS CUI [1])
Informed Consent
Item
7. signed informed consent document on file.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cisplatin allergy | Cisplatin allergy Suspected | Hypersensitivity Vinorelbine | Hypersensitivity Suspected Vinorelbine
Item
1. patients are diagnosed or suspected to be allergic to cisplatin or vinorelbine.
boolean
C0570702 (UMLS CUI [1])
C0570702 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0078257 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0750491 (UMLS CUI [4,2])
C0078257 (UMLS CUI [4,3])
Hemorrhagic Disorder
Item
2. patients with concomitant hemorrhagic disease.
boolean
C0019087 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
3. pregnant or breast feeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Use of Conduit gastric Unable | Status post Esophagectomy | Etiology Operative Surgical Procedures Previous
Item
4. inability to use gastric conduit after esophagectomy because of a prior surgery.
boolean
C1524063 (UMLS CUI [1,1])
C0441247 (UMLS CUI [1,2])
C0038351 (UMLS CUI [1,3])
C1299582 (UMLS CUI [1,4])
C0231290 (UMLS CUI [2,1])
C0085198 (UMLS CUI [2,2])
C0015127 (UMLS CUI [3,1])
C0543467 (UMLS CUI [3,2])
C0205156 (UMLS CUI [3,3])
Peripheral Neuropathy CTCAE Grades
Item
5. patients with concomitant peripheral neuropathy, whose ctc status is 2 or even more.
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Malignant Neoplasms | Exception Esophageal carcinoma | Exception Carcinoma in situ of uterine cervix | Exception Skin carcinoma | Exception Prostate carcinoma Early stage Cured
Item
6. have a prior malignancy other than esophageal carcinoma, carcinoma in situ of the cervix, nonmelanoma skin cancer or cured early stage of prostate cancer.
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0152018 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C0699893 (UMLS CUI [4,2])
C1705847 (UMLS CUI [5,1])
C0600139 (UMLS CUI [5,2])
C2363430 (UMLS CUI [5,3])
C0679252 (UMLS CUI [5,4])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial